251 related articles for article (PubMed ID: 35050692)
21. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
Grau-Expósito J; Perea D; Suppi M; Massana N; Vergara A; Soler MJ; Trinite B; Blanco J; García-Pérez J; Alcamí J; Serrano-Mollar A; Rosado J; Falcó V; Genescà M; Buzon MJ
PLoS Pathog; 2022 Jan; 18(1):e1010171. PubMed ID: 35025963
[TBL] [Abstract][Full Text] [Related]
24. The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells.
Kelesidis T; Madhav S; Petcherski A; Cristelle H; O'Connor E; Hultgren NW; Ritou E; Williams DS; Shirihai OS; Reddy ST
Virulence; 2021 Dec; 12(1):2214-2227. PubMed ID: 34494942
[TBL] [Abstract][Full Text] [Related]
25. In search of preventive strategies: novel high-CBD
Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
[TBL] [Abstract][Full Text] [Related]
26. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
Garcia G; Sharma A; Ramaiah A; Sen C; Purkayastha A; Kohn DB; Parcells MS; Beck S; Kim H; Bakowski MA; Kirkpatrick MG; Riva L; Wolff KC; Han B; Yuen C; Ulmert D; Purbey PK; Scumpia P; Beutler N; Rogers TF; Chatterjee AK; Gabriel G; Bartenschlager R; Gomperts B; Svendsen CN; Betz UAK; Damoiseaux RD; Arumugaswami V
Cell Rep; 2021 Apr; 35(1):108940. PubMed ID: 33784499
[TBL] [Abstract][Full Text] [Related]
27. Lectin from
Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545
[TBL] [Abstract][Full Text] [Related]
28. Multi-level inhibition of coronavirus replication by chemical ER stress.
Shaban MS; Müller C; Mayr-Buro C; Weiser H; Meier-Soelch J; Albert BV; Weber A; Linne U; Hain T; Babayev I; Karl N; Hofmann N; Becker S; Herold S; Schmitz ML; Ziebuhr J; Kracht M
Nat Commun; 2021 Sep; 12(1):5536. PubMed ID: 34545074
[TBL] [Abstract][Full Text] [Related]
29. Cellular host factors for SARS-CoV-2 infection.
Baggen J; Vanstreels E; Jansen S; Daelemans D
Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
[TBL] [Abstract][Full Text] [Related]
30. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.
Humphries F; Shmuel-Galia L; Jiang Z; Wilson R; Landis P; Ng SL; Parsi KM; Maehr R; Cruz J; Morales-Ramos A; Ramanjulu JM; Bertin J; Pesiridis GS; Fitzgerald KA
Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010139
[TBL] [Abstract][Full Text] [Related]
31. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
van de Leemput J; Han Z
Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
[TBL] [Abstract][Full Text] [Related]
32. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
[TBL] [Abstract][Full Text] [Related]
33. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
[TBL] [Abstract][Full Text] [Related]
34. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey EE; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33811184
[TBL] [Abstract][Full Text] [Related]
36. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
[TBL] [Abstract][Full Text] [Related]
37. Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro.
Murray J; Hogan RJ; Martin DE; Blahunka K; Sancilio FD; Balyan R; Lovern M; Still R; Tripp RA
Sci Rep; 2021 Sep; 11(1):18085. PubMed ID: 34508172
[TBL] [Abstract][Full Text] [Related]
38. Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
Bhatt AN; Kumar A; Rai Y; Kumari N; Vedagiri D; Harshan KH; Chinnadurai V; Chandna S
Life Sci; 2022 Apr; 295():120411. PubMed ID: 35181310
[TBL] [Abstract][Full Text] [Related]
39. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
40. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
Varghese FS; van Woudenbergh E; Overheul GJ; Eleveld MJ; Kurver L; van Heerbeek N; van Laarhoven A; Miesen P; den Hartog G; de Jonge MI; van Rij RP
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
